Ceo and expert interviews

Cyclopharm (ASX:CYC) on pathway to US sales

11 Dec 2020 - Cyclopharm Limited (ASX:CYC) CEO & Managing Director James McBrayer talks about USFDA approval for Technegas, the company's USA commercialisation plan, and opportunities beyond its key diagnostic market for pulmonary embolism.

Read more...